The DOI matches its Crossref record; 42 of the 45 references it cites were found in a registry or an index.
Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells
Abstract
apoE-deficient mice have been created by homologous recombination in ES cells. On a low fat, low cholesterol chow diet these animals have plasma cholesterol levels of 494 mg/dl compared with 60 mg/dl in control animals, and when challenged with a high fat Western-type diet, these animals have plasma cholesterol levels of 1821 mg/dl compared with 132 mg/dl in controls. This marked hypercholesterolemia is primarily due to elevated levels of very low and intermediate density lipoproteins. At 10 weeks of age, apoE-deficient mice have already developed atherosclerotic lesions in the aorta and coronary and pulmonary arteries. apoE-deficient mice are a promising small animal model to help understand the role of apoE in vivo and the genetic and environmental determinants of atherosclerosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The increased amounts of apoA-IV in VLDL and IDL we observed were seen in other reports of apoE deficiency4,5,9 and in apoE-deficient mice.31”
From Effects of the Absence of Apolipoprotein E on Lipoproteins, Neurocognitive Function, and Retinal Function (2014) · cites this paper as [31]
In the citing paper
“Increased amounts of apoA-I were observed in LDL from an apoE-deficient patient9 and in VLDL from ApoE knockout mice.31”
From Effects of the Absence of Apolipoprotein E on Lipoproteins, Neurocognitive Function, and Retinal Function (2014) · cites this paper as [31]
In the citing paper
“Disorders of apoE are associated with atherosclerosis, which causes dyslipidemia and myocardial infarction, and apoE-deficient mice are used as model animals for atherosclerosis2, 3).”
From Impact of Apolipoprotein E Variants: A Review of Naturally Occurring Variants and Clinical Features (2025) · cites this paper as [3]
In the citing paper
“Disorders of apoE are associated with atherosclerosis, which causes dyslipidemia and myocardial infarction, and apoE-deficient mice are used as model animals for atherosclerosis2, 3).”
From Impact of Apolipoprotein E Variants: A Review of Naturally Occurring Variants and Clinical Features (2025) · cites this paper as [3]
In the citing paper
“In vivo and in vitro studies have shown that mutations in apoE that diminish binding of apoE-containing lipoproteins to the LDL receptor are associated with high plasma cholesterol levels and cause premature atherosclerosis in humans and experimental animals ( 1-3, 7, 8 ).”
From Molecular etiology of a dominant form of type III hyperlipoproteinemia caused by R142C substitution in apoE4 (2011) · cites this paper as [1]
Citations
Cites
Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction
Chomczynski, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1006/abio.1987.9999 · Cited by 65,515
Weber, K., & Osborn, M. (1969) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)94333-4 · Cited by 16,688
Apolipoprotein E: Cholesterol Transport Protein with Expanding Role in Cell Biology
Mahley, R. W. (1988) · Science · doi:10.1126/science.3283935 · Cited by 4,028
The Metabolic Basis of Inherited Disease
(1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-112-5-389_2 · Cited by 3,990
Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells
Thomas, K. R., & Capecchi, M. R. (1987) · Cell · doi:10.1016/0092-8674(87)90646-5 · Cited by 2,355
Apolipoprotein E polymorphism and atherosclerosis.
Davignon, J., Gregg, R. E., & Sing, C. F. (1988) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.8.1.1 · Cited by 1,981
Mansour, S. L., Thomas, K. R., & Capecchi, M. R. (1988) · Nature · doi:10.1038/336348a0 · Cited by 1,683
HPRT-deficient (Lesch–Nyhan) mouse embryos derived from germline colonization by cultured cells
Hooper, M., Hardy, K., Handyside, A. H., Hunter, S., & Monk, M. (1987) · Nature · doi:10.1038/326292a0 · Cited by 1,218
A novel form of tissue-specific RNA processing produces apolipoprotein-B48 in intestine
Powell, L. M., Wallis, S. C., Pease, R. J., Edwards, Y. H., Knott, T. J., & Scott, J. (1987) · Cell · doi:10.1016/0092-8674(87)90510-1 · Cited by 1,045
Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI
Rubin, E. M., Krauss, R. M., Spangler, E. A., Verstuyft, J. G., & Clift, S. (1991) · Nature · doi:10.1038/353265a0 · Cited by 985
Self-citationQuantitative assessment of atherosclerotic lesions in mice
Paigen, B. J., Morrow, A., Holmes, P. A., Mitchell, D., & Williams, R. A. (1987) · Atherosclerosis · doi:10.1016/0021-9150(87)90202-4 · Cited by 951
Piedrahita, J. A., Zhang, S. H., Hagaman, J. R., Oliver, P. M., & Maeda, N. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.10.4471 · Cited by 944
Teratocarcinomas and embryonic stem cells: A practical approach
Krumlauf, R. K. (1987) · Trends in Genetics · doi:10.1016/0168-9525(87)90286-1 · Cited by 779
Apolipoprotein B-48 Is the Product of a Messenger RNA with an Organ-Specific In-Frame Stop Codon
Chen, S. H., Habib, G. M., Yang, C., Gu, Z.-W., Lee, B. R., Weng, S. A., Silberman, S. R., Cai, S.-J., Deslypère, J. P., Rosseneu, M., et al. (1987) · Science · doi:10.1126/science.3659919 · Cited by 756
Variation in susceptibility to atherosclerosis among inbred strains of mice
Paigen, B. J., Morrow, A. L., Brandon, C. W., MITCHELL, D., & HOLMES, P. (1985) · Atherosclerosis · doi:10.1016/0021-9150(85)90138-8 · Cited by 614
Transport and Storage of Vitamin A
Blomhoff, R., Green, M. H., Berg, T., & Norum, K. R. (1990) · Science · doi:10.1126/science.2218545 · Cited by 609
Zannis, V. I., & Breslow, J. L. (1981) · Biochemistry · doi:10.1021/bi00507a059 · Cited by 563
Self-citationProposed nomenclature of apoE isoproteins, apoE genotypes, and phenotypes
Zannis, V. I., Breslow, J. L., Utermann, G., Mahley, R. W., Weisgraber, K. H., Havel, R. J., Goldstein, J. L., Brown, M. S., Schonfeld, G., Hazzard, W. R., et al. (1982) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38094-9 · Cited by 436
Self-citationZijlstra, M., Li, E., Sajjadi, F., Subramani, S., & Jaenisch, R. (1989) · Nature · doi:10.1038/342435a0 · Cited by 347
Familial apolipoprotein E deficiency.
Schaefer, E. J., Gregg, R. E., Ghiselli, G., Forte, T. M., Ordovas, J. M., Zech, L. A., & Brewer, H. B. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112704 · Cited by 313
Synthetic low and high fat diets for the study of atherosclerosis in the mouse.
Nishina, P. M., Verstuyft, J. G., & Paigen, B. (1990) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)42785-3 · Cited by 293
Self-citationPaigen, B., Mitchell, D., Reue, K., Morrow, A. L., Lusis, A. J., & LeBoeuf, R. C. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.11.3763 · Cited by 288
Hixson, J. E. (1991) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.11.5.1237 · Cited by 286
Type III Hyperlipoproteinemia Associated with Apolipoprotein E Deficiency
Ghiselli, G., Schaefer, E. J., Gascon, P., & Breser, H. B. (1981) · Science · doi:10.1126/science.6795720 · Cited by 274
Weintraub, M. S., Eisenberg, S., & Breslow, J. L. (1987) · Journal of Clinical Investigation · doi:10.1172/jci112926 · Cited by 261
Self-citationWalsh, A., Ito, Y., & Breslow, J. L. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)83374-9 · Cited by 239
Self-citationType III Hyperlipoproteinemia: Diagnosis, Molecular Defects, Pathology, and Treatment
BREWER, H. B., ZECH, L. A., GREGG, R. E., SCHWARTZ, D., & SCHAEFER, E. J. (1983) · Annals of Internal Medicine · doi:10.7326/0003-4819-98-5-623 · Cited by 226
Production of a mutation in mouse En-2 gene by homologous recombination in embryonic stem cells
Joyner, A. L., Skarnes, W. C., & Rossant, J. (1989) · Nature · doi:10.1038/338153a0 · Cited by 195
Davidson, N. O., Powell, L. M., Wallis, S. C., & Scott, J. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)68263-8 · Cited by 190
Diet-induced hypercholesterolemia in mice: prevention by overexpression of LDL receptors
Yokode, M., Hammer, R. E., Ishibashi, S., Brown, M. S., & Goldstein, J. L. (1990) · Science · doi:10.1126/science.2244210 · Cited by 175
Production and analysis of chimeric mice
Bradley, A. (1987) · Cited by 174
Utermann, G., Steinmetz, A., & Weber, W. (1982) · Human Genetics · doi:10.1007/bf00569216 · Cited by 149
Shimano, H., Yamada, N., Katsuki, M., Shimada, M., Gotoda, T., Harada, K., Murase, T., Fukazawa, C., Takaku, F., & Yazaki, Y. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.5.1750 · Cited by 143
Jiao, S., Cole, T. G., Kitchens, R. T., Pfleger, B. A., & Schonfeld, G. (1990) · Metabolism · doi:10.1016/0026-0495(90)90069-o · Cited by 136
Kates, M., Palameta, B., Joo, C. N., Kushner, D. J., & Gibbons, N. E. (1966) · Biochemistry · doi:10.1021/bi00876a044 · Cited by 132
Cladaras, C., Hadzopoulou-Cladaras, M., Felber, B. K., Pavlakis, G., & Zannis, V. I. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)61655-2 · Cited by 92
A young type III hyperlipoproteinemic patient associated with apolipoprotein E deficiency
Mabuchi, H., Itoh, H., Takeda, M., Kajinami, K., Wakasugi, T., Koizumi, J., Takeda, R., & Asagami, C. (1989) · Metabolism · doi:10.1016/0026-0495(89)90249-7 · Cited by 70
Tennyson, G. E., Sabatos, C. A., Higuchi, K., Meglin, N., & Brewer, H. B. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.2.500 · Cited by 61
Accumulation of human apolipoprotein E in the plasma of transgenic mice.
Smith, J. D., Plump, A. S., Hayek, T., Walsh, A., & Breslow, J. L. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)77166-4 · Cited by 45
Self-citationStructure and Expression of Mouse Apolipoprotein E Grene1
Horiuchi, K., Tajima, S., Menju, M., & Yamamoto, A. (1989) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a122828 · Cited by 39
The influence of apolipoprotein polymorphism on the response to dietary fat and cholesterol
Abbey, M. (1992) · Current Opinion in Lipidology · doi:10.1097/00041433-199202000-00003 · Cited by 22
(1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.8.2657 · Cited by 8
Cited by
Sorted by citations
Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
Chitosan Chemistry and Pharmaceutical Perspectives
Kumar, M. N. V. R., Müzzarelli, R. A. A., Muzzarelli, C., Sashiwa, H., & Domb, A. J. (2004) · Chemical Reviews · doi:10.1021/cr030441b · Cited by 2,945
The biochemistry and medical significance of the flavonoids
Havsteen, B. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00298-x · Cited by 2,702
Macrophages in atherosclerosis: a dynamic balance
Moore, K. J., Sheedy, F. J., & Fisher, E. A. (2013) · Nature reviews. Immunology · doi:10.1038/nri3520 · Cited by 2,559
Nahrendorf, M., Swirski, F. K., Aikawa, E., Stangenberg, L., Wurdinger, T., Figueiredo, J.-L., Libby, P., Weissleder, R., & Pittet, M. J. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070885 · Cited by 2,300
Metadata
- Authors
- Plump, A. S., Smith, J. D., Hayek, T., Aalto-Setälä, K., Walsh, A., Verstuyft, J. G., Rubin, E. M., & Breslow, J. L.
- Affiliations
- Rockefeller University (US)
- Lawrence Berkeley National Laboratory (US)
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 1992-10
- Volume
- 71
- Issue
- 2
- Pages
- 343-353
- ISSN
- 0092-8674 (ISSN-L)
- OpenAlex
- W2048890665
- Cited by
- 2,263
- References
- 45
- Citations by year
- 2026: 23 · 2025: 41 · 2024: 28 · 2023: 32 · 2022: 52 · 2021: 39 · 2020: 60 · 2019: 69 · 2018: 57 · 2017: 66 · 2016: 57 · 2015: 71 · 2014: 71 · 2013: 82 · 2012: 75
- FWCI
- 72.03
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Cell (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01hl033714-17)
- National Heart, Lung, and Blood Institute (HL 33714, R01HL032435, HL32435)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Keywords
- apolipoprotein E deficiency, hypercholesterolemia, atherosclerosis, ApoE-deficient mice, homologous recombination, embryonic stem cells, serum cholesterol, VLDL, intermediate density lipoprotein, high-fat diet, aortic atherosclerotic lesions, coronary arteries, pulmonary artery, animal models of atherosclerosis
- MeSH terms
- Animals, Aorta, Apolipoproteins E, Arteriosclerosis, Cholesterol, Coronary Vessels, Disease Models, Animal, Hypercholesterolemia, Lipoproteins, Lipoproteins, VLDL, Mice, Inbred BALB C, Mice, Inbred C57BL, Mice, Transgenic, Pulmonary Artery, Stem Cells, Mice, Lipoproteins, IDL
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
